NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
1.500
-0.060 (-3.85%)
Sep 14, 2026, 4:00 PM EDT - Market closed
NMTC Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 2.05 | 6.57 | 1.46 | 5.32 | 8.16 | 6.9 |
Short-Term Investments | - | - | - | - | 2.98 | - |
Cash & Short-Term Investments | 2.05 | 6.57 | 1.46 | 5.32 | 11.14 | 6.9 |
Cash Growth | -74.53% | 350.01% | -72.57% | -52.23% | 61.44% | 70.98% |
Receivables | 1.1 | 1.26 | 0.18 | - | 0.03 | 0.05 |
Inventory | 2.29 | 2.23 | 2.64 | 1.73 | 0.7 | 0.1 |
Prepaid Expenses | 0.32 | 0.14 | 0.22 | 0.26 | 0.3 | 0.15 |
Other Current Assets | 0.03 | 0.02 | 0.14 | - | - | 0.09 |
Total Current Assets | 5.79 | 10.23 | 4.63 | 7.31 | 12.18 | 7.29 |
Property, Plant & Equipment | 0.37 | 0.51 | 0.67 | 0.69 | 0.53 | 0.51 |
Other Intangible Assets | 0.03 | 0.04 | 0.07 | 0.09 | 0.11 | 0.13 |
Total Assets | 6.19 | 10.79 | 5.37 | 8.1 | 12.82 | 7.94 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 0.91 | 1.01 | 1.03 | 0.69 | 0.93 | 0.53 |
Accrued Expenses | 0.93 | 1.17 | 1.06 | 0.98 | 0.63 | 0.53 |
Current Portion of Leases | 0.1 | 0.12 | 0.07 | 0.13 | 0.08 | 0.11 |
Current Unearned Revenue | - | - | - | - | 1.46 | 0.01 |
Other Current Liabilities | 0.1 | 0 | 0.06 | - | - | - |
Total Current Liabilities | 2.04 | 2.3 | 2.21 | 1.79 | 3.1 | 1.18 |
Long-Term Leases | 0.07 | 0.14 | 0.19 | 0.06 | 0.12 | 0.2 |
Other Long-Term Liabilities | 0.3 | 1.27 | 2.14 | - | - | - |
Total Liabilities | 2.42 | 3.71 | 4.55 | 1.85 | 3.22 | 1.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 0.01 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 |
Additional Paid-In Capital | 88.19 | 85.63 | 75.8 | 68.91 | 60.41 | 47.37 |
Retained Earnings | -84.44 | -78.61 | -75 | -62.69 | -50.83 | -40.83 |
Shareholders' Equity | 3.77 | 7.07 | 0.82 | 6.25 | 9.6 | 6.55 |
Total Liabilities & Equity | 6.19 | 10.79 | 5.37 | 8.1 | 12.82 | 7.94 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 0.18 | 0.27 | 0.26 | 0.18 | 0.2 | 0.32 |
Net Cash (Debt) | 1.87 | 6.3 | 1.2 | 5.14 | 10.94 | 6.59 |
Net Cash Growth | -75.82% | 425.35% | -76.65% | -53.03% | 66.09% | 150.06% |
Net Cash Per Share | 0.22 | 0.94 | 0.27 | 1.70 | 4.10 | 3.69 |
Filing Date Shares Outstanding | 9.11 | 8.4 | 5.14 | 3.99 | 2.71 | 2.7 |
Total Common Shares Outstanding | 8.7 | 8.33 | 5.14 | 3.99 | 2.7 | 2 |
Working Capital | 3.75 | 7.92 | 2.42 | 5.52 | 9.08 | 6.11 |
Book Value Per Share | 0.43 | 0.85 | 0.16 | 1.57 | 3.55 | 3.27 |
Tangible Book Value | 3.74 | 7.03 | 0.75 | 6.16 | 9.49 | 6.42 |
Tangible Book Value Per Share | 0.43 | 0.84 | 0.15 | 1.54 | 3.51 | 3.21 |
Machinery | 1.16 | 1.06 | 0.98 | 0.86 | 0.54 | 0.31 |